chitosan has been researched along with Congestive Ophthalmopathy in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jiang, S; Liu, D; Wang, Q; Wei, C; Wu, M; Xiong, H; Yi, H; Yi, T; Zhou, X; Zhou, Y; Zou, H | 1 |
1 other study(ies) available for chitosan and Congestive Ophthalmopathy
Article | Year |
---|---|
Chitosan inhibits inflammation and adipogenesis of orbital fibroblasts in Graves ophthalmopathy.
Topics: Adipocytes; Adiponectin; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; CCAAT-Enhancer-Binding Proteins; Cell Cycle; Cell Differentiation; Cell Survival; Chitosan; Cyclooxygenase 2; Dinoprostone; Fatty Acid-Binding Proteins; Female; Fibroblasts; Gene Expression Regulation; Graves Ophthalmopathy; Humans; Interleukin-1beta; Interleukin-6; Male; MAP Kinase Kinase 4; Middle Aged; Orbit; PPAR gamma; Primary Cell Culture; Proto-Oncogene Proteins c-akt; Signal Transduction | 2018 |